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Modulation of Hexokinase Association with Mitochondria Analyzed with 
Quantitative Three-Dimensional Confocal Microscopy 
Ronald M. Lynch, Kevin E. Fogarty, and Fredric S. Fay 
Department of Physiology, University of Massachusetts Medical Center, Worcester, Massachusetts 01655 
Abstract. Hexokinase isozyme I is proposed to be as- 
sociated with mitochondria n vivo. Moreover, it has 
been suggested that this association is modulated in
coordination with changes in cell metabolic state. To 
test these hypotheses, we analyzed the subcellular dis- 
tribution of hexokinase r lative to mitochondria n
paraformaldehyde-fixed astrocytes using immunocyto- 
chemistry and quantitative three-dimensional confocal 
microscopy. Analysis of the extent of colocalization 
between hexokinase and mitochondria revealed that 
,070% of cellular hexokinase is associated with mito- 
chondria under basal metabolic onditions. In contrast 
to the immunocytochemical studies, between 15 to 
40% of cellular hexokinase was found to be associated 
with mitochondria after fractionation of astrocyte cul- 
tures depending on the exact fractionation conditions. 
The discrepancy between fractionation studies and 
those based on imaging of distributions in fixed cells 
indicates the usefulness of using techniques that can 
evaluate the distributions of "cytosolic" enzymes in 
cells whose subcellular ultrastructure is not severely 
disrupted. To determine if hexokinase distribution is
modulated in concert with changes in cell metabolism, 
the localization of hexokinase with mitochondria was 
evaluated after inhibition of glucose metabolism with 
2-deoxyglucose. After incubation with 2-deoxyglucose 
there was an approximate 35 % decrease in the amount 
of hexokinase associated with mitochondria. These 
findings upport he hypothesis that hexokinase is
bound to mitochondria n rat brain astrocytes in vivo, 
and that this association is sensitive to cell metabolic 
state. 
H 
EXOK INASE I is the primary isoform of hexokinase 
found in brain (21), and a number of insulin-sensi- 
tive tissues (2, 18, 20) and tumorigenic cells (14, 17). 
The majority of this hexokinase appears to be associated 
with mitochondria nmany of these cell types. Although up 
to 85 % of brain hexokinase can be associated with mito- 
chondria fter tissue fractionation, it has been suggested that 
only a small amount of hexokinase is associated with mito- 
chondria in astrocytes (11). When associated with mitochon- 
dria, the affinity of the enzyme for one of its substrates (ATP) 
is elevated, and sensitivity to inhibition by its product 
glucose-6-phosphate (G-6-P)' is lowered (23). Thus, the in- 
teraction of hexokinase I with mitochondria s proposed to 
be kinetically advantageous. Furthermore, the association of 
hexokinase with mitochondria is proposed to be regulated in
vivo. This hypothesis i  based on the observation that he in- 
teraction of hexokinase with mitochondria s sensitive to the 
concentrations of several ions and metabolites. The principal 
modulator of hexokinase binding to mitochondria may be 
G-6-P, since this metabolite will release hexokinase from 
isolated mitochondria (17, 23). This effect of G-6-P is coun- 
teracted by physiological levels of inorganic phosphate. From 
1. Abbreviations used in this paper: G-6-P, glucose-6-phosphate; MITO 
IMP, inner mitochondrial membrane epitope; 2DG, 2-deoxyglucose; 2DG- 
6-P, 2DG-6-phosphate. 
this and other in vitro evidence, it is postulated that he as- 
sociation of hexokinase with mitochondria s modulated in 
concert with changes in the rate of glycolysis (23). Accord- 
ing to this model, inhibition of glycolysis leads to an increase 
in the concentration f G-6-P and release of hexokinase from 
mitochondria, thereby decreasing the activity of hexokinase 
I. Conversely, stimulation of metabolism by increasing cell 
work would decrease G-6-P, increase inorganic phosphate, 
and promote binding leading to an enhancement i  the effi- 
cacy of hexokinase I. Although the modulation of hexokinase 
binding to mitochondria has been detailed in vitro, the hy- 
pothesis that hexokinase distribution is regulated in vivo re- 
mains controversial (8). In the present study, we have evalu- 
ated the subcellular distribution of hexokinase inan astrocyte 
cell line, and monitored the modulation of this distribution 
during alteration of cell metabolism, using monoclonal nti- 
bodies raised against rat brain hexokinase I and indirect im- 
munofluorescence-imaging techniques. 
Materials and Methods 
Cell Culture 
Astrocytes were obtained after the second passage from J. L. Leonard 
(University of Massachusetts Medical Center, Worcester, MA). The primary 
cultures were prepared from embryonic rat brain as previously described 
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(9), Cells were grown in 10-cm 2 culture dishes using DMEM sup- 
plemented with 10% FIBS, 1000 U/ml penicillin G, 10 mg/ml streptomycin 
sulfate, and without phenol red. Cells were used between passages 3 and 
8 for all experiments described. For immunoeytoehemical experiments, 
cells were grown on 22-mm round coverslips, plated at an initial density 
of 106 cells/plate and used after cells had become confluent (10-14 d after 
plating). 
Immunocytochemistry 
Cells were fixed with 4% filtered paraformaldehyde in PBS (20 mM; pH 
7.8) for 15 rain. Plates were washed in phosphate buffer, and the unreacted 
fixative was quenched with 0.1 mM glycine. Cells were then permeabilized 
with 0.25% Triton in 10 mM sodium citrate buffer (pH 7.8) for 20 min. 
Monoelonal antibodies to hexokiuase were kindly provided by John E. Wil- 
son and Allen D. Smith (Michigan State University, East Lansing, MI), and 
have been previously characterized (26). In single-label xperiments, cells 
were incubated with the primary monoclonal antibody (0.05 mg/ml), 
washed, and then incubated with a fluorophore labeled anti-mouse IgG. In 
the absence of permeabilization, no significant labeling with antibodies was 
observed. In dual-label experiments, two different monocloual antibodies 
were used for the independent localization of mitochondria and hexokinase. 
The monocioual ntibody used for identification ofmitochondria was raised 
to an inner membrane epitope (3), and was purchased from Bioproducts for 
Science (Indianapolis, IN). To label each antibody with a specific fluoro- 
phore conjugated anti-mouse IgG, a blocking step was used after fluoro- 
phore labeling of the first monoclonal antibody. Nonfluorophore labeled 
anti-mouse IgG was used as the blocking agent. This step assured that all 
free sites for anti-mouse IgG interaction were covered before the second 
series of monoclonal nd secondary labeled antibodies. Thus, a typical dual- 
label experiment consisted of incubation with an antihexokinase mono- 
clonal antibody followed by Texas red conjugated anti-mouse IgG (rabbit 
affinity purified), then unlabeled anti-mouse IgG (goat affinity purified). 
After this blocking step, cells were incubated sequentially with the mono- 
clonal antibody to the inner mitochondrial membrane epitope (MITO IMP) 
and a fluorescein conjugated anti-mouse IgG (sheep). Fluorescein labeling 
observed after deletion of the second monoclonal ntibody, provided amea- 
sure of the efficacy of the blocking step. Experiments were deemed accept- 
able only when fluorescein labeling in the blocked controls was comparable 
to that seen in cells incubated with the fluorescein-conjugated anti-mouse 
IgG alone. 
Fluorescence Microscopy and Image Analysis 
Confocal Microscopy. Fluorophore-labeled antibodies were used to iden- 
tify the subcellular location of mitochondria and hexokinase in fixed cells. 
To analyze the amount of hexokinase that was associated with mitochondria 
within a cell, information concerning the distribution of the respective 
fluorescent markers throughout the cell was required. This was necessary 
because the distribution of mitochondria s nonuniform with some areas of 
the cell being rich in mitochondria and others relatively mitochondria free. 
To analyze the three-dimensional (3D) distributions ofhexokinase and mito- 
chondria, a confocal microscope was used to acquire sequential through- 
focus images of labeled cells. A laser-scanning confocal microscope (model 
MRC-500; Bio-Rad Laboratories, Richmond, CA) equipped with a plana- 
po oil (63X) immersion lens (n.a. = 1.4) was used for these experiments. 
The confocal microscope, unlike standard widefield microscopes, directly 
rejects out-of-focus light providing improved resolution along the z-axis 
at a cost to signal/noise (21). The aperture size of the confocal pinhole de- 
termines the relation between z-axis resolution and the signal/noise char- 
acteristics of the microscope (25). In the present work, pinholes on the mi- 
croscope, for both fluorophores, were set to allow collection of '~80% of 
the emitted light observed when pinholes are opened completely. These set- 
tings provided a full width at half maximum integrated intensity (image 
plane depth of field) of •0.9 #m (21). 3D image sets were obtained by ac- 
quiring 8-10 optical slices at 0.5-#m intervals. Dual-wavelength images 
were acquired using 488-nm excitation and two independent transmission 
filters, one centered at 525-nm (fluorescein) and the other a 600-nm long 
pass filter (Texas red). Before analysis, all images were corrected for dark 
current and instrument background. The contribution of fluorescence from 
the fluorescein signal to the image of Texas red was small, and did not 
significantly alter the estimated values for hexokinase distribution. Correc- 
tion for the contribution of fluorescence from the fluorescein signal into the 
Texas red channel was evaluated according to the equation (expression 1)
Ftr= (Itr -- If * a)/0 - a * b) where I refers to measured fluorescence in- 
tensity, Fthe noncontaminated signal (no spinover), and coefficients a and 
b refer to the % leakthrough ofthe fluorescein signal into the Texas red win- 
dow, and the reciprocal spillover of Texas red signal into the fluorescein 
channel, respectively. Subscripts: f, fluorescein; tr, Texas red. Expression 
(/) is derived from the simultaneous solution of the equations which de- 
scribe the origin of fluorescence signal in each channel: lt~ = Ft, + Ff * a, 
and If = Ff + Ft, * b. We determined that coefficients a and b were equal 
to 0.11 -1- 0.2 (n = 6) and 0.09 ± 0.1 (n = 6) by measuring the fluorescence 
leakthrough from singly labeled samples. These values for percent spillover 
are specific for the gain and black level settings chosen for this experiment 
on our confocal microscope. From expression 1, the Texas red signal can 
be corrected for spitlover from fluorescein i any dual label image set using 
the measured values of fluorescence intensity in each channel (Ix) and the 
previously determined coefficients. Independent correction of the Texas red 
signal values for the entire cell image and the mitoehondrial masked portion 
of the image allowed us to determine that spillover would lower the esti- 
mated values of % hexokinase bound to mitochondria by <5 %. Results 
presented in the text are not corrected for spillover because this correction 
is small under the conditions of this experiment. All images were acquired 
within 6 h of sample preparation to assure sample stability. 
Photobleaching of Sample. The rate of photobleaching during image ac- 
quisition was determined by measuring the rate of decrease inemitted light 
intensity from a uniformly fluorescent sample during the identical protocol 
used to collect the 3D data sets from labeled cells. To imitate the pho- 
tobleaching of a labeled cell, a uniformly fluorescent sample was prepared. 
The sample was 3% gelatin labeled with the appropriate fluorophore by in- 
cubation for 30 min while cooling to 25°C with the succinimidyl ester 
derivative of the fluorophore. The measured rate of photobleaching is de- 
pendent on the characteristics of the specific imaging protocol. In experi- 
ments, a single image scan took 0.125 s, and 20 scans were averaged for 
a single plane of focus. Therefore, the bleach rate given is a measure of 
bleaching which occurs over integrals (frames) which is related to an abso- 
lute constant of 2.5 s/image frame. Using this procedure we found that, for 
Texas red, the rate of decline in fluorescence intensity as a function of the 
image frame fit an exponential function with a decay constant of 
-0.0055%/frame. The value for the rate of photobleaching was used to 
scale sequential image frames from cells where hexokinase was labeled with 
Texas red. The rate of photobleaching of fluorescein was very high thereby 
making the fluorescein signal difficult o quantitate. For this reason hexoki- 
nase was always labeled with Texas red. Correction for photobleaching was 
not carried out for the fluorescein anti-IMP images, since these images were 
used simply to provide amap of mitochondrial location and not for quantita- 
tive signal analysis. 
Correction for Nonspecific Label. There was a uniform and low level 
of nonspecific fluorescence labeling in the cell because of the use of 
ftuorophore-conjugated nti-mouse IgGs to label the primary monoclonal 
antibodies. To obtain an estimate of the actual amount of specific labeling, 
a value for the level of this nonspecific labeling must be subtracted from 
all hexokiuase-specific mages. In algebraic terms: the fraction of hexo- 
kinase which is associated with mitochondria na given cell = (I;im - INS 
• Pm]) / (Tic - [NC* Pc]), where i represents the intensity value of individ- 
ual pixels, i is the sum of pixel intensities, NS is the mean grey level of 
nonspecific fluorescence, and P is the number of picture elements as- 
sociated with the mitochondria (subscript m) or the entire cell (subscript 
c). Nonspecific fluorescence associated with the hexokinase image was as- 
sessed by two methods: (a) in several experiments cells were incubated with 
the Texas red anti-mouse IgG alone, and therefore, no specific labeling was 
present in these samples. 3D image sets were obtained from multiple cells, 
then background subtracted and corrected for photobleaching. An average 
intensity value for nonspecific labeling was then calculated from these 
bleach corrected images; and (b) previous evidence suggested that the 
specific labeling of hexokinase in the nuclei of neural tissue (22) and astro- 
cytes (11) was negligible. In our experiments, it also was determined that 
antihexokinase does not significantly label the nucleus. To test this cells 
were incubated with both secondary fluorophore labeled anti-mouse IgGs 
in the absence of a primary monoclonal ntibody (both nonspecific label- 
ing), or with specific labeling of the antihexokinase with Texas red. The 
level of labeling in distinct subcellular regions was compared between the 
fluorescein image (nonspecific label), and the Texas red image of the same 
cell (either specific or nonspecific label). When antihexokinase was present, 
the Texas red/fluorescein ratio in cytosolic regions was 100-10,000-fold 
higher than that measured in ceils with the antihexokinase omitted. On the 
other hand, the ratio of Texas red/fluorescein fluorescence in nuclear regions 
was not significantly different when cells were specifically labeled with anti- 
hexokinase Texas red. Thus, specific labeling of the nucleus with antihexo- 
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kinase is insignificant. The absolute fluorescence intensity in the nucleus 
was 20% greater than in the cytoplasm (nonnuciear regions) in cells in- 
cubated with the Texas red-conjugated secondary antibody alone. This 
difference is likely because of a higher capacity of nuclear material to bind 
secondary antibody "nonspecifically: Nuclear values were scaled by this 
factor before use in correcting for nonspecific labeling. Based on these 
findings, intensity of fluorescence in the nucleus was used as a measure of 
nonspecific labeling in individual cells. 
Determination fMitochondrial Location and Associated Hexokinase. 
Mitochondrial-associated h xokinase was determined by first constructing 
a binary mask of mitocbondria location from the image of fluorescein-labeled 
anti-MITO IMP, as described below. This mask was then used to evaluate 
the distribution of hexokinase inthe bleach-corrected hexnkinase image from 
the same cell. Since only mitochondria were specifically stained in the fluores- 
cein image, an intensity threshold could in theory be used to remove the 
nonspecific labeling. However, there was some heterogeneity n the inten- 
sity of staining between individual mitochondria which made it difficult o 
set a global intensity threshold without introducing error in the assignment 
of pixels corresponding to mitochondria, particularly those that were lightly 
labeled. To compensate for the different levels of labeling of individual 
mitochondria, the intensity distribution of light from all regions within the 
image was first adjusted using a locally adaptive histogram equalization al- 
gorithm (16). A single global intensity threshold could then be chosen to 
eliminate most of the nonmitochondrial b ckground without significant loss 
of mitochondrial regions. To remove the remaining nonmitochondrial pix- 
els, data sets were searched in 3D for pixels which had no more than one 
neighbor, indicating that they were from random noise and not mitochon- 
dria. These isolated pixels were removed from the data set to provide a 3D 
spatial map of mitochondrial distribution within a cell. A binary mask was 
prepared by assigning a value of one to all pixels that remained in the data 
set, i.e., those associated with mitochondria. Subsequent multiplication of
the hexokinase image with the binary mask provides a final image which 
represents only the hexokinase that is associated with mitochondria. This 
image of mitochondria-associated hexokinase was normalized to the total 
amount of hexokinase (nonmasked image) in the same cell to provide ameasure 
of the fraction of hexokinase which was associated with mitochondria atthe 
time of fixation. 
Metabolite Measurements 
G-6-P was measured in cell suspensions. Cells were removed from culture 
flasks with a plastic cell scraper and incubated at 37"C at a density of "~107 
cells/ml. Suspensions were analyzed for cell density, protein mass, and cell 
volume. Cell density was measured in the presence of 0.25 % trypsin using 
a hemocytometer, and cell volume was estimated from the volume of the 
cell pellet following centrifugation in hematocrit tubes (13). Cell mass was 
assumed to account for "~5 % of total cell volume the remainder being water. 
Metabolic inhibitors were added directly to the suspensions. Experiments 
were terminated by the addition of'lV_.A (final concentration 0.1%) and cen- 
trifugation at 8,000 g for 5 min. The supernatant was neutralized by the ad- 
dition of a small amount (<1% vol/vol) of Tris buffer (pH 12), then analyzed 
for G-6-P content using an enzyme-linked spectrophotometric assay (10). 
Since 2-deoxyglucose (21)13) inhibits G-6-P utilization by G-6-P dehydrogenase 
contained in the assay system, the samples were allowed to incubate in the 
assay buffer for 20 min at room temperature b fore analysis. Time course 
studies howed that his period was sufficient to allow for complete enzymatic 
oxidation of the G-6-P without any significant decrease inabsorbance of control 
samples. 
Cell Fractionation 
Procedures used for fractionation are essentially those reported by Black- 
shear et al. (4). Cells were scraped from culture flasks in medium contain- 
ing (mmol/liter): sucrose, 350; EGTA, 0.5; Hepes, 10; pH 7.4 (condition 
A), or in the same Hepes-sucrose-based medium without EGTA, but con- 
taining MgC12, 1.5; and NaH2PO,, 1.0 (condition B). Cells in suspension 
were disrupted using a Dounce homogenizer with a Teflon pestle. The ho- 
mogenate was centrifuged at 3,500 g for 5 rain to collect nuclei and un- 
broken cells. The resulting supernatant was centrifuged at 20,000 g for 20 
min to collect he mitochondrial nd plasma membrane fragments. Finally, 
the remaining supernatant was centrifuged at115,000 g for 60 rain to sepa- 
rate the remaining microsomal particles from the soluble cell fraction 
(aqueous cytosol). Triton X-100 was added to the cytosolic fraction to a 
final level of 0.1%. All pellets were resuspended in fractionation media con- 
taining 0.1% triton. Hexokinase activity was measured inall fractions using 
the standard enzyme-linked assay (10). Data are expressed as a percent of 
the sum of hexokinase activity found in the three primary fractions; mito- 
chondriai, microsomal, and cytosolic. These three fractions accounted for 
>90% of the activity in the original homogenate. The remaining activity 
was likely to be associated with unbroken cells residing in the slow speed 
pellet after homogenization. 
Materials 
Cell culture media, FBS, and penicillin/streptomycin sulfate solution were 
purchased from Gibco Laboratories (Grand Island, NY). Fluorophore- 
labeled antibodies were obtained from Caibiochem-Behring Corp. (San 
Diego, CA), and unlabeled anti-mouse IgG was purchased from Amersham 
Corp. (Arlington Heights, IL). All substrates, sugars, and metabolic inhibi- 
tors were purchased from Sigma Chemical Co., (St. Louis, MO). All other 
chemicals were of analytical grade and were obtained from commercial 
sources. 
Mathematical Treatment ofData 
Data are presented as means +SEM. Statistical differences between means 
were determined using an unpaired t test. P < 0.05 was taken as a statisti- 
cally significant difference between group means. 
Results 
Localization of Hexokinase by 
Immunofluorescence Cytochemistry 
Two monoclonal antibodies were used to analyze the sub- 
cellular distribution of endogenous hexokinase in parafor- 
maldehyde-fixed astrocytes. These antibodies designated 21 
and 2B are directed against epitopes located in the NH2- 
terminal half of the hexokinase molecule (26). Hexokinase 
is found to be highly localized within the astrocytes using ei- 
ther monoclonal antibody (Fig. 1; and see Fig. 3 B). The 
regions of dense staining resemble mitoehondria seen in 
other cells. To determine if the localized hexokinase was 
specifically associated with mitochondria, we used several 
markers for analyzing the subcellular distribution of these 
organelles. 
Mitochomtrial Location 
The dye rhodamine 123 was used to observe mitochondria 
and their distribution in living astrocytes. Rhodamine 123 
partitions into mitochondria because of the high transmito- 
chondrial membrane potential difference (5), and therefore, 
may be used to determine mitochondrial location in living 
cells. As seen in Fig. 2 A, mitochondria are heterogeneous 
in size, and distributed throughout the cell. Most mitochon- 
dria are found near the nucleus, with others less frequently 
found in the peripheral regions. To determine the spatial dis- 
tribution of mitochondria n fixed cells, we used a monoclo- 
nal antibody raised against an inner mitochondrial mem- 
brane protein (anti-MITO IMP) (3). As shown in Fig. 2 B, 
the anti-MITO IMP displays apattern of distribution within 
astrocytes which is similar to that observed with rhodamine 
123 in living cells. Thus, the inner mitochondrial membrane 
antibody provides an excellent means to determine subcellu- 
lar mitochondrial distribution. 
Colocalization of Hexokinase and Mitochondria 
To determine the extent o which hexokinase is associated 
with mitochondria n astrocytes, cells were incubated with 
antibodies to both mitochondria nd hexokinase. These 
monoclonal antibodies were independently abeled with 
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Figure 1. Confocal image of 
the distribution of hexokinase 
in fixed astrocytes. Monoclo- 
hal antibody 2B was used to 
label endogenous cellular hex- 
okinase. This is an original 
image obtained in single wave- 
length mode (rhodamine) with 
a total integration time of 2 
rain. Notice that much of the 
label is localized to regions 
that resemble mitochondria in 
shape. (N) nuclei. Bar, 25 ~,m. 
Figure 2. Fluorescence images of mitochondria n living (A) and fixed (B) astrocytes. (A) Rhodamine 123 labeled living astrocyte. Cell 
was incubated with 1 mg/ml rhodamine 123 for I rain, then rinsed in physiological saline. Note that mitochondria h ve several characteristic 
shapes being either punctate in appearance (dart), or 2-3-~m long (arrows). (B) Anti-MITO IMP labeled fixed astrocyte. Note that the 
antimitochondrial marker ecognizes structures id ntical in shape to those labeled with rhodamine 123. Images were acquired using a Photo- 
metrics CCD camera mounted on a microscope (model IM-35; Zeiss, Oberkochen, FRG). Bar, 10 ~,m. 
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Figure 3. Confocal images of a fixed astrocyte labeled with antihexokinase, and anti-MITO IMP. The images shown result from the projec- 
tion onto a single image plane of eight nonprocessed through focal images of the cell taken at 0.5/~m intervals. (A) Distribution of the anti- 
MITO IMP labeled with fluorescein. (B) Hexokinase distribution assessed using the monoclonal antibody 21 with a Texas red secondary 
label. Note the high degree of correspondence between the regions with a high density of exokinase (B) and the mitochondria (,4). 
Bar, 10/~m. 
fluorescein or Texas red conjugated-secondary antibodies, 
respectively (see Materials and Methods). The distributions 
of the two fluorophore-labeled antibodies were analyzed 
simultaneously and independently using a confocal micro- 
scope. As seen in Fig. 3, points of high hexokinase localiza- 
tion align with regions determined tobe mitochondria by the 
anti-MITO IMP. Although exokinase appears to be primar- 
ily associated with mitochondria,  significant level of more 
uniformly distributed fluorescence is also observed. This 
low level of uniform fluorescence is in part related to non- 
specific labeling by the fluorophore-conjugated anti-mouse 
IgG, as well as, some level of nonlocalized specifically la- 
beled hexokinase. Fig. 4 A shows the distribution of bexo- 
kinase in the image plane where the majority of mitochon- 
dria reside. This image is corrected for nonspecific labeling 
using a mean intensity value obtained from the nucleus of 
this cell. Fig. 4 B shows the binary mitochondrial mask pre- 
pared from the image of the fluorescein-labeled anti-MITO 
IMP in this cell. Multiplication of these two image sets pro- 
vides a final image set of the cellular hexokinase which is as- 
sociated with mitochondria n three dimensions. The amount 
of hexokinase in this 3D data set is compared to the amount 
of hexokinase in the entire cell to obtain an estimate of the 
amount of cellular hexokinase which is associated with mito- 
chondria t the time of fixation. In two independent experi- 
ments the amount of total cellular hexokinase associated 
with mitochondria was found to be 72.7 % (Table I) and 64.6 
± 5.2% (SEM; n = 8) using the nuclear intensity of each 
cell as a correction for nonspecific labeling. Similar values 
for mitochondria-associated hexokinase were obtained when 
nonspecific labeling was estimated from multiple cells in- 
cubated only with the Texas red-conjugated anti-mouse IgG 
(Table I). Thus, both measures of nonspecific labeling pro- 
vide similar estimates of percent hexokinase associated with 
mitochondria. However, use of the nuclear value on a cell 
by cell basis provides a significant decrease in variability, as 
indicated by the lower SD of the measurement (Table I). 
Without correction for nonspecific labeling, values for 
mitochondrial-associated h xokinase of 35.6% and 30.6 ± 
1.7 % are calculated for these two experiments. Therefore, at 
minimum 30-40% of the cellular bexokinase is localized to 
mitochondria. However, based on the good agreement be- 
tween two independent measures of nonspecific fluores- 
cence, it is likely that ,,070% of the cells hexokinase is as- 
sociated with mitochondria n these astrocytes under basal 
metabolic onditions. 
Modulation of Hexokinase Distribution 
The specific localization of hexokinase with mitochondria s 
proposed to be modulated inassociation with changes in the 
rate of glycolysis (23). G-6-P has been shown to modulate 
binding of hexokinase to mitochondria n vitro, suggesting 
a primary regulatory role. Under control conditions (10 m 
M glucose), G-6-P is ,x,0.2 m M (0.24 + 0.2 mM; n = 6), 
as measured incells incubated in suspension. G-6-P concen- 
tration was altered by incubation with the inhibitor of glycol- 
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Figure 4. Confocal images of a fixed astrocyte labeled with antihexokinase, and anti-MITO IMP. The images shown are of a single focal 
plane from a through focal series. Theplane shown corresponds to that having the highest density of mitochondria. (A) Distribution of 
antihexokinase. This image has been digitally corrected fornonspecific labeling using information regarding the intensity of nuclear fluores- 
cence, as described in Materials and Methods. (B) Represents the binary mask for mitochondrial location prepared from the anti-MITO 
IMP distribution, as described in Materials and Methods. Bar, 10 #m. 
ysis, 2DG (10 mM), in the presence of lowered glucose (1 
mM). 2DG elicits a fourfold increase in G-6-P in suspended 
cells after 1 h (0.94 + 0.13 mM; n = 3). Images of hex- 
okinase and mitochondrial location were acquired from con- 
trol and 2DG-treated ceils, and then analyzed for the percent 
of cell hexokinase associated with mitochondria. 1 h of incu- 
bation with 2DG resulted in an ~35% decrease in the 
amount of hexokinase associated with mitochondria (Table 
Table L The Percent Hexokinase Associated 
with Mitochondria* 
Control 2DG 
Method of Correction 
for Nonspecific Label 
No correction 35.6 25.1 
+2.1 +1.7 
Estimate from non- 62.3 45.5 
specific labeled cells -I-5.2 +4.2  
Estimate from nuclear 72.7 46.4 
region of each cell +3.2 +3.8 
n (10) (9) 
* Hexokinase associated with mitochondrial mask, Total cell hexokinase in 3D 
cell data set. 
+SEM; (n) number of images analyzed. 
I). The distribution of hexokinase in the central image plane 
of a control and 2DG-treated cell is shown in Fig. 5. The to- 
tal amount of hexokinase in the 3D data sets of these two 
cells is approximately equal, however, the amount of hex- 
okinase associated with mitochondria was 81% in the control 
and 39% in the 2DG-treated cell. Fig. 6 shows images of the 
mitochondrial-associated, an  nonmitochondrial-associated 
hexokinase in the central focal plane from these two cells in 
pseudocolor (a linear color scale has been used to show the 
level of hexokinase localized within the images). As can be 
seen, mitochondria are densely labeled with hexokinase in 
the control cell but less so in the 2DG-treated cell. On the 
other hand, there are no obvious regions of localization of 
hexokinase in the nonmitochondrial images. Since there is 
a 35 % decrease in the amount of hexokinase associated with 
mitochondria after treatment with 2DG, it is likely that the 
released hexokinase is uniformly distributed throughout the 
cell and not sequestered into other distinct structures. 
Hexokinase Distribution Assessed from 
Fractionation Studies 
Previous tudies based on fractionation techniques indicated 
that a large proportion of hexokinase was associated with the 
soluble phase of primary astrocytes (80 % cytosol), and only 
20% with the total cell particulate fraction containing mito- 
chondria (11). However, our immunocytological evidence 
demonstrates that for the most part hexokinase is associated 
with mitochondria n astrocytes. To determine if differences 
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Figure 5. Confocal images of fixed astrocytes labeled with antihexokinase. Shown are single image planes of hexokinase distribution fr m 
a cell incubated with 10 mM glucose (A), and a cell treated with 2DG for I h before fixation (B). These are original images towhich 
no processing has been applied. The percent hexokinase associated with the mitochondria was 81% for the control cell (A) and 39% for 
the 2DG-treated cell. The total intensity of fluorescence from the Texas red labeled antihexokinase in the 3D-image sets was similar for 
both cells. 
in the observed istributions reflect differences in cell types 
used, or are associated with fractionation, primary astro- 
cytes were fractionated under conditions similar to those 
used in the previous report and hexokinase activity wasas- 
sessed in each fraction. As seen in Table II, •80% of the cell 
hexokinase activity was found in the soluble phase. Only a 
minor amount (--15 %) of hexokinase was found in the high 
speed particulate fraction which contained both mitochon- 
dria and plasma membrane particles. It is possible that the 
low level of hexokinase associated with the mitochondrial 
fraction is related to the specific onditions under which the 
cell fractionation was performed. For example, the fraction- 
ation experiment in Table II, condition A was carried out in 
media containing EGTA without Mg 2+. However, Mg 2+ has 
been shown to promote hexokinase association with isolated 
mitochondria (17, 23). To test if fractionation conditions 
could affect the measured hexokinase activity in the mito- 
chondria fraction, a second fractionation experiment was 
performed in the presence of promoters of hexokinase bind- 
ing to isolated mitochondria. In the presence of Mg 2+ and 
inorganic phosphate there was a significantly higher percent- 
age of hexokinase in the mitoch0ndrial fraction (36%). In 
addition, there was an increase in the amount of hexokinase 
found in the microsomal pellet (Table II; condition B). This 
later finding may be due to the collection of submitochon- 
drial membranes containing hexokinase in the microsomal 
pellet, or a specific association of hexokinase with another 
membrane component in this fraction. If the activity in the 
microsomal fraction is assumed to be of mitochondrial ori- 
gin, then at most 45 % of the cells' hexokinase is found to be 
associated with mitochondria when fractionation is carried 
out in the presence of Mg 2+. Under either fractionation 
condition, values for mitochondrial-associated h xokinase 
were significantly lower than estimates made using the imag- 
ing approach with these primary astrocytes. 
Discussion 
In the present work, we have demonstrated that hexokinase 
isozyme I is associated with mitochondria nglial cells main- 
tained in culture. Our estimate based on immunocytochemi- 
cal studies is that '~70 % of the cells' complement ofhexoki- 
nase I is associated with mitochondria under basal metabolic 
conditions. This estimate is considerably higher than that 
based on fractionation studies carried out with these cells in 
the presence or absence of factors which promote hexoki- 
nase binding in vitro (Table II; also see reference 11). While 
fractionation studies provide valuable analysis of the distri- 
butions of tightly bound or integral membrane proteins, it 
appears that such methods may beless reliable for molecules 
whose associations with subcellular surface appear to be 
regulated. Since fractionation studies require disruption of 
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Table II. Hexokinase Activity in Cell Fractions 
Mitochondria plasma 
membrane fraction Microsomes Cytosol 
% Total Hexokinase Activity 
Condition A 15.9% 3.1% 81.0% 
+ SEM 1.8 0.6 7.1 
Condition B 34.6% 7.8% 55.8% 
+ SEM 1.0 0.5 4.0 
Condition A. Hepes-sucrose buffer with EGTA. Condition B: Hepes-sucrose 
buffer; no EGTA with Mg 2÷ and inorganic phosphate. Fractions were pre- 
pared as described in methods. SEM are based on at least triplicate measure- 
ments performed onall fractions prepared in a single xperiment. 
the cell and replacement of the "cytosol" with a physiological 
buffer, it is likely that hexokinase distribution is altered ur- 
ing the fractionation procedure depending on the exact na- 
ture of the fractionation media (Table II). Thus, a primary 
advantage of the imaging approach is that hexokinase is pre- 
sumably fixed into place within the cell before analysis. In 
this respect, the ability to quantitate the relative distribution 
of a protein at a specific site in a fixed preparation may be 
of general use for assigning location to enzymes whose dis- 
tributions may be dynamic. 
It could be argued that the high relative levels of hexoki- 
nase associated with mitochondria is caused by preferential 
loss of the unbound enzyme during preparation of samples 
before imaging. Several findings indicate that the unbound 
component of hexokinase is not lost during sample prepara- 
tion. First, free bexokinase is found to increase after treat- 
ment with 2DG, indicating that free hexokinase is preserved. 
Second, hexokinase isnot labeled significantly with antihexo- 
kinase if cells are not permeabilized, yet immunoblots of 
fixed and fixed and permeabilized samples indicate that no 
significant loss of hexokinase occurred uring the permea- 
bilization procedure (data not shown). Thirdly, fluorescently 
labeled native hexokinase localizes to mitochondria follow- 
ing its injection into living astrocytes, and fixation does not 
elicit a visible change in this distribution (unpublished ob- 
servations). Thus, the antibody labeling procedure appears 
to provide an adequate measure of the distribution of endoge- 
nous hexokinase at the :time of fixation. 
The release of hexokinase from mitochondria observed af- 
ter treatment with 2DG indicates that hexokinase localiza- 
tion can be modulated in the intact cell (Table I; Fig. 6). In 
vitro studies of hexokinase association with isolated mito- 
chondria suggest that hexokinase binding to mitochondria s
sensitive to many factors including the concentrations of cer- 
tain metabolites (G-6-P; Pi) and ions (Mg~+; H+). For ex- 
ample, hexokinase bound to mitochondria s released in the 
presence of millimolar amounts of G-6-P. On the other hand, 
physiological levels of Mg 2÷ or Pi promote binding and re- 
verse the G-6-P effect (17, 23). Fractionation data presented 
in Table II are consistent with these previous observations. 
These observations have led to the hypothesis that changes 
in the rate of glycolysis modulate hexokinase binding to mi- 
tochondria. Since the levels of and interactions between the 
various effectors in vivo are not known with certainty, ques- 
tions remain concerning the modulation of hexokinase distri- 
bution in response to changes in cell metabolism (8). 2DG 
was used to inhibit glycolysis in astrocytes before fixation. 
2DG is phosphorylated to 2DG-6-phosphate (2DG-6-P) by 
hexokinase, but is not metabolized further. As 2DG levels in- 
crease within the cell, the rate of G-6-P removal by hexose 
isomerase and G-6-P dehydrogenase d crease because of in- 
hibition by 2DG-6-P. After 1 h of incubation with 2DG, G-6-P 
levels increased fourfold, and therefore, 2DG-6-P levels also 
are presumed elevated. Thus, the significant decrease in 
mitochondrial-associated h xokinase that occurred in the 
presence of elevated G-6-P (Table I; Fig. 4) is consistent with 
the hypothesis that hexokinase distribution can be modulated 
in association with changes in cell metabolism. 
Alterations in the kinetic properties of hexokinase caused 
by its association with the outer mitochondrial membrane 
have been reported. The bound form of hexokinase exhibits 
a higher affinity (lower Kin) for ATP (24), and a decreased 
susceptibility o inhibition by G-6-P (19) than does the solu- 
ble form. In addition, for hexokinase bound to mitochondria 
isolated from ascites cells, the rate of hexokinase turnover 
(G-6-P production) is elevated when ATP is supplied from 
endogenous mitochondrial oxidative phosphorylation rela- 
tive to ATP added to the incubation medium (1). These ob- 
servations suggest that important kinetic and functional ad- 
vantages are conferred through association of the enzyme 
with specific sites at the outer mitochondrial membrane. In
light of these findings, it has been proposed that binding of 
hexokinase to the outer mitochondrial membrane l ads to an 
increase in the efficacy of the hexokinase reaction (23). It 
should be noted that recent evidence suggests that hexoki- 
nase may not be directly bound to the outer mitochondrial 
membrane in brain, but rather on some other structure 
which cosediments with mitochondria during standard frac- 
tionation procedures (15). Based on our findings, this bind- 
ing structure is either intimately associated with mitochon- 
dria in astrocytes, or these recent observations are specific 
for brain cells other than astrocytes. 
Figure 6. Pseudocolor images of antihexokinase distribution in cells grown in normal medium and in the presence of 2DG. Images of 
mitochondrial ssociated (Aand B) and nonmitochondrial associated hexokinase (C and D) from a control cell (A and C) and a cell treated 
with 10 mM 2DG for 1 h before fixation (B and D). The mitochondria-associated b xokinase images are prepared by multiplication of 
the respective binary masks with the antihexokinase images (Fig. 4). Nonmitochondria-associated hexokinase images are prepared by sub- 
traction of the mitochondria-associated h xokinase image from the antihexokinase image (Fig. 5). A linear color scale is used with red 
indicating the highest levels of hexokinase and blue the lowest levels. Note the high density of labeling in the mitochondrial-associated 
hexokinase images relative to the nonmitochondria-associated hexokinase images: In images of nonmitochondrial hexokinase distribution 
there are few points of high hexokinase that can be observed. These points are likely to be mitochondrial regions which were not included 
in the mask by the algorithm used to generate it. This occurs occasionally due to weak staining of edges of mitochondria by the anti-MITt 
IMP. However, it is clear from the low number of these points that the mask provides an excellent indicator of mitochondrial location 
in the hexokinase images. Notice that nonmitochondrial hexokinase is low and uniformly distributed in both cells. Bar, 10 #m. 
Lynch et al. Hexokinase Association with Mitochondria 393 
 o
n









 Published February 1, 1991
Historically, quantitation of protein localization at specific 
subcellular sites has been carried out by techniques, such as 
differential centrifugation, which require disruption of cell 
integrity. In the present report, we present an approach 
which uses indirect immunofluorescence and 3D-imaging 
techniques to simultaneously identify the distributions of 
specific structures and proteins under conditions were cell 
ultrastructure is maintained. The quantitation of relative dis- 
tributions using this approach may be of general use, particu- 
larly in respect to proteins whose subcellular distributions 
may be dynamic. 
Quantitative Confocal Microscopy 
The approach that we have taken to assess the amount of hexo- 
kinase which is associated with discrete structures (mito- 
chondria) relative to that which is uniformly distributed is 
based on our ability to acquire a series of high-resolution 
fluorescence images taken at regular intervals throughout a 
cell. This has been achieved in the present study with the use 
of a laser-scanning confocal microscope whose pinholes 
have been closed to the point where both good z-axis resolu- 
tion and signal/noise are retained in each image of the 3D 
image series. Potentially, 3D data with similar or even better 
z resolution can be obtained using conventional wide-field 
microscopy coupled with appropriate image restoration to 
remove out-of-focus blurring (6). Use of such a system may 
be more appropriate for investigations of living systems 
where the low transmission characteristics and cell photo- 
damage caused by continuous laser illumination may limit 
the use of the confocal microscope. However, a primary 
benefit of the confocal microscope is that it provides 3D in- 
formation directly, thereby eliminating the need for addi- 
tional postprocessing in these studies. 
The ability to acquire images with limited contribution 
from out-of-focus light allows for evaluation of fluorophore 
distributions from through-focus image series with only mi- 
nor correction. First, correction for photobleaching between 
sequential image planes was performed. Second, correction 
for nonspecific labeling of the cells by the fluorophore con- 
jugated secondary antibodies was carried out. Two methods 
were used for estimation of the level of nonspecific labeling. 
Use of values obtained by either approach gave similar mean 
values for the percent of hexokinase associated with mito- 
chondria. However, the usage of the mean grey level from 
a nuclear region as a correction factor significantly de- 
creased the SE, indicating the usefulness of using a measure 
which can be applied on a cell by cell basis. Based on the 
present results, it is likely that 3D microscopy coupled with 
appropriate image processing as described in this paper will 
allow for analysis of the dynamic association of specific mol- 
ecules with distinct subcellular structures in a wide range of 
biological questions. 
In summary, we have used quantitative confocal micros- 
copy and immunocytochemical techniques to investigate the 
subcellular distribution of hexokinase in astrocytes grown in 
culture. Approximately 70% of the hexokinase is associ- 
ated with mitochondria in these cells under control condi- 
tions (10 mM glucose). After inhibition of glycolysis with 
2DG the amount of hexokinase associated with mitochondria 
decreased by '~35 %. Therefore, these findings support the 
hypothesis that a significant amount of hexokinase is colocal- 
ized with mitochondria in astrocytes in vivo, and that this 
specific distribution is dynamically modulated inresponse to 
changes in cell metabolic state. 
We would like to thank John E. Wilson and Allen Smith (Michigan State 
University, East Lansing, MI) for their critical review of this work, as well 
as for kindly providing the hexokinase antibodies. We would also like to 
acknowledge the intellectual contributions of Drs. Walter Carrington and 
Larry Lifshitz (University of Massachusetts Medical Center, Worcester, 
MA) to this manuscript. 
Generation and characterization ofmonoclonal ntibodies to hexokinase 
were supported by National Institutes of Health NS 09910 (to J. E. Wilson). 
R. M. Lynch was the recipient of a Charles A. King Fellowship during the 
tenure of this study. This work was supported by grants from the National 
Institutes of Health (DK-32520) to the Diabetes and Endocrinology Re- 
search Center at the University of Massachusetts Medical Center, and 
HL14323 to F. S. Fay. 
Received for publication 12 April 1990 and in revised form 23 October 
1990. 
References 
1. Arora, K. K., and P. L. Pedersen. 1988. Metabolic significance of mito- 
chondrial associated hexokinase in tumor cell metabolism: evidence for 
preferential phosphorylation f glucose by intramitochondrially gener- 
ated ATP. J. Biol. Chem. 263:17422-17428. 
2. Aubert-Foucher, E., B. Font, and D. C. Gantheron. 1984. Rabbit heart mi- 
tochondrial hexokinase: solubilization and general properties. Arch. Bio- 
chem. Biophys. 232:391-399. 
3. Billet, E. E., B. Gunn, and R. J. Mayer. 1984. Characterization f two 
monoclonal ntibodies obtained after immunization with human liver mi- 
tochondrial membrane preparations. Biochem. J. 221:765-776. 
4. Blackshear, P. L., R. A. Nemenoff, and J. Avruch. 1983. Insulin and 
growth factor stimulate the phosphorylation f a Mr-22,000 protein in 
3T3-L1 adipocytes. Biochem. J. 214:11-19. 
5. Chen, L. B. 1988. Mitochondrial membrane potential in living cells. Annu. 
Rev. Cell Biol. 4:155-181. 
6. Fay, F. S., W. Carrington, and K. E. Fogarty. 1989. Three-dimansional 
molecular distribution in single cells analyzed using the digital imaging 
microscope. J. Microsc. (Oxf). 153:133-149. 
7. Kao-Jen, J., and J. E. Wilson. 1980. Localization of hexokinase inneural 
tissue: electron microscopic studies of rat cerebellar cortex. J. Neu- 
rochem. 35:667-678. 
8. Kyriazi, H. T., and R. E. Basford. 1986. An examination of the in vivo 
distribution of brain hexokinase between the cytosol and outer mitochon- 
drial membrane. Arch. Biochem. Biophys. 248:253-271. 
9. Leonard, J. L. 1988. Dibutyryl cAMP induction of type II 5'deiodinase ac- 
tivity in rat brain astrocytes inculture. Biochem. Biophys. Res. Commun. 
151:1164-1176. 
10. Lowry, O. H., and J. V. Passormeau. 1976. In A flexible system of enzy- 
matic analysis. Academic Press Inc., Orlando, FL. pp. 174 and 194. 
11. Lusk, J. A., C. M. Manthorpe, J. Kao-Jen, and J. E. Wilson. 1980. Pre- 
dominance of the cytoplasmic form of brain hexokinase incultured astro- 
cytes. J. Neurochem. 34:1412-1420. 
12. Deleted in proof. 
13. Lynch, R. M., and R. S. Balaban. 1987. Coupling of aerobic glycolysis 
and Na-K ATPase in the renal cell line MDCK. Am. J. Physiol. 253(Cell 
Physiol. 22):C269-276. 
14. Parry, D. M., and P. L. Pedersen. 1983. Intracellular localization and prop- 
erties of particulate hexokinase inNovikoff ascites tumor. J. Biol. Chem. 
258:10904-10912. 
15. Parry, D. M., and P. L. Pedersen. 1990. Glucose catabolism inbrain. Intra- 
cellular localization of hexokinase. J. Biol. Chem. 265:1059-1066. 
16. Pizer, S., J. D. Austin, R. Cromartie, G. Geselowitz, and B. H. ter Haar 
Romey. 1986. Algorithms for adaptive histogram equalization, S.P.I.E. 
( Soc. Photop. Instr. Eng.) 671 : 132-138. 
17. Rose, I. A., and J. V. B. Warms. 1967. Mitochondriai hexokinase: release, 
binding and location. J. Biol. Chem. 242:1635-1645. 
18. Sener, A., F. Mallaisse-Lagae, M. Giroix, and W. J. Mallaisse. 1986. 
Hexokinase metabolism inpancreatic islets: compartmentation of hexoki- 
nase in islet cells. Arch. Biochem. Biophys. 251:61-67. 
19. Turtle, J. P., and J. E. Wilson. 1970. Rat brain hexokinase: a kinetic com- 
parison of soluble and particulate forms. Biochim. Biophys. Acta. 212: 
185-188. 
20. Waiters, E., and P. McLean. 1968. Effect of anti-insulin serum and alloxan- 
diabetes on the distribution of multiple forms of hexokinase in lactating 
rat mammary gland. Biochem. J. 109:737-741. 
21. Wells, K. S., D. R. Sandison, J. Stricker, andW. W. Webb. 1989. Quan- 
titative fluorescence imaging with laser scanning confocal microscopy. In 
The handbook of biological confocal microscopy. J. Pawley, editor. Pie- 
The Journal of Cell Biology, Volume 112, 1991 394 
 o
n









 Published February 1, 1991
num Press, NY. 27-39. 
22. Wilkin, G. P., and J. E. Wilson. 1977. Localization of hexokinase inneural 
tissue: light microscopic studies with immunofluorescence and histo- 
chemical procedures. J. Neurochem. 29:1039-1051. 
23. Wilson, J. E. 1980. Brain hexokinase; the prototype ambiquitous enzyme. 
Curr. Top. Cell. ReguL 16:1--44. 
24. Wilson, J. E. 1988. Function of ambiquitous proteins in a heterogeneous 
medium. In Microcompartmentation. D. P. Jones, editor. CRC Press 
Inc., Boca Raton, FL. 171-190. 
25. Wilson, T. 1989. The role of the pinhole in confocal imaging systems. In 
The handbook of biological confocal microscopy, J. Pawley, editor. Ple- 
num Press, NY. 113-126. 
26. Wilson, J. E., and A. D. Smith. 1985. Monoclonal antibodies to rat brain 
hexokinase. J. Biol. Chem. 260:12838-12845. 
Lynch et al. Hexokinase Association with Mitochondria 395 
 o
n









 Published February 1, 1991
